// App-Quantinova.ai

875 : Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

Researchers

Presenter

  • Natasha Amrita Satkunam

Principal Investigators

  • Johnny Mahlangu

  • Christoph Bidlingmaier

  • Prasad Mathew

  • Paula D. James

  • Maria Eva Mingot-Castellano

  • Meera B. Chitlur

  • Patrick F. Fogarty

  • Adam Cuker

  • Maria Elisa Mancuso

  • Pal Andre Holme

  • Julie Grabell

  • Wilma Hopman

Medical Centers

  • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, Milan, Italy

  • Department of Oncology, Queens University, Kingston, ON, Canada

  • Department of Clinical Research, Queen's University, Kingston, Canada

  • Carman and Ann Adams Department of Pediatrics, Division of Hematology/Oncology, Children's Hospital of Michigan/Wayne State University, Detroit, MI

  • Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

  • Univ. of NM Health Science Ctr., Albuquerque, NM

  • University of Pennsylvania, Philadelphia, PA

  • Department of Oncology, Oslo University Hospital, Oslo, Norway

  • Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

  • Regional University Hospital Carlos Haya, Malaga, Spain

  • Dr. von Haune-s Children's University Hospital, Munich, Germany

  • Queen's University, Kingston, ON, CA

Locations

  • Canada

  • Italy

  • Norway

  • Spain

  • Germany

  • United States

Companies

  • Bayer

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Hemophilia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved